Literature DB >> 22823020

Lipophilicity in drug discovery.

Michael J Waring1.   

Abstract

IMPORTANCE OF THE FIELD: The role of lipophilicity in determining the overall quality of candidate drug molecules is of paramount importance. Recent developments suggest that, as well as determining pre-clinical ADMET (absorption, distribution, metabolism, elimination and toxicology) properties, compounds of optimal lipophilicity might have increased chances of success in development. AREAS COVERED IN THIS REVIEW: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compound 'quality' with lipophilicity. WHAT THE READER WILL GAIN: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region. TAKE HOME MESSAGE: The review of the data shows that this optimal space is defined by a narrow range of logD between ∼ 1 and 3. Some of the implications of this for medicinal chemistry optimisation are discussed.

Year:  2010        PMID: 22823020     DOI: 10.1517/17460441003605098

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN: 1746-0441            Impact factor:   6.098


  112 in total

Review 1.  Finding the sweet spot: the role of nature and nurture in medicinal chemistry.

Authors:  Michael M Hann; György M Keserü
Journal:  Nat Rev Drug Discov       Date:  2012-04-30       Impact factor: 84.694

Review 2.  The influence of the 'organizational factor' on compound quality in drug discovery.

Authors:  Paul D Leeson; Stephen A St-Gallay
Journal:  Nat Rev Drug Discov       Date:  2011-09-30       Impact factor: 84.694

3.  Roles of affinity and lipophilicity in the slow kinetics of prostanoid receptor antagonists on isolated smooth muscle preparations.

Authors:  R L Jones; D F Woodward; J W Wang; R L Clark
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

Review 4.  Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.

Authors:  Céline Passeleu-Le Bourdonnec; Pierre-Alain Carrupt; Jean Michel Scherrmann; Sophie Martel
Journal:  Pharm Res       Date:  2013-06-26       Impact factor: 4.200

5.  Heteroaromatic and aniline derivatives of piperidines as potent ligands for vesicular acetylcholine transporter.

Authors:  Junfeng Li; Xiang Zhang; Zhanbin Zhang; Prashanth K Padakanti; Hongjun Jin; Jinquan Cui; Aixiao Li; Dexing Zeng; Nigam P Rath; Hubert Flores; Joel S Perlmutter; Stanley M Parsons; Zhude Tu
Journal:  J Med Chem       Date:  2013-07-18       Impact factor: 7.446

6.  Combretastatin A4-β-Galactosyl Conjugates for Ovarian Cancer Prodrug Monotherapy.

Authors:  Tomohiro Doura; Kazuaki Takahashi; Yasumitsu Ogra; Noriyuki Suzuki
Journal:  ACS Med Chem Lett       Date:  2017-01-20       Impact factor: 4.345

7.  Utility of Physicochemical Properties for the Prediction of Toxicological Outcomes: Takeda Perspective.

Authors:  Tomoya Yukawa; Russell Naven
Journal:  ACS Med Chem Lett       Date:  2020-01-29       Impact factor: 4.345

8.  Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement.

Authors:  Isaac E Marx; Thomas A Dineen; Jessica Able; Christiane Bode; Howard Bregman; Margaret Chu-Moyer; Erin F DiMauro; Bingfan Du; Robert S Foti; Robert T Fremeau; Hua Gao; Hakan Gunaydin; Brian E Hall; Liyue Huang; Thomas Kornecook; Charles R Kreiman; Daniel S La; Joseph Ligutti; Min-Hwa Jasmine Lin; Dong Liu; Jeff S McDermott; Bryan D Moyer; Emily A Peterson; Jonathan T Roberts; Paul Rose; Jean Wang; Beth D Youngblood; Violeta Yu; Matthew M Weiss
Journal:  ACS Med Chem Lett       Date:  2016-09-21       Impact factor: 4.345

9.  Ligand-based virtual screening identifies a family of selective cannabinoid receptor 2 agonists.

Authors:  Matteo Gianella-Borradori; Ivy Christou; Carole J R Bataille; Rebecca L Cross; Graham M Wynne; David R Greaves; Angela J Russell
Journal:  Bioorg Med Chem       Date:  2014-11-08       Impact factor: 3.641

10.  New benzenesulphonohydrazide derivatives as potential antitumour agents.

Authors:  Łukasz Popiołek; Monika Gawrońska-Grzywacz; Anna Berecka-Rycerz; Kinga Paruch; Iwona Piątkowska-Chmiel; Dorota Natorska-Chomicka; Mariola Herbet; Anna Gumieniczek; Jarosław Dudka; Monika Wujec
Journal:  Oncol Lett       Date:  2020-09-02       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.